Statements (68)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Businessman
|
| gptkbp:associatedWith |
gptkb:Pfizer_Inc.
|
| gptkbp:hasAwards |
Pharmaceutical_Executive_of_the_Year
|
| gptkbp:hasClient |
Biotechnology
|
| gptkbp:hasContribution |
Research_and_Development_in_Pharmaceuticals
|
| gptkbp:hasEducation |
gptkb:University_of_Michigan
|
| gptkbp:hasEvents |
Expanded_Pfizer's_product_line
|
| gptkbp:hasFacility |
gptkb:Pfizer_Inc.
Charles_Pfizer_II Sophie_Pfizer |
| gptkbp:hasFeature |
Clinical Trials
Health Economics Mental Health Public Health Chronic Disease Management Infectious Diseases Vaccine Development Corporate Governance Healthcare Innovation Market Access Regulatory Affairs Cardiovascular Health Drug Development Patient Advocacy Rare Diseases Pharmaceutical Manufacturing Drug Safety Pharmaceutical Distribution Pediatric Health Pharmaceutical Pricing Pharmaceutical Regulation Health Technology Assessment Diabetes Research Health Policy Advocacy Pharmaceutical Ethics Oncology Research Pharmaceutical Marketing Pharmaceutical Policy Pharmaceutical Supply Chain Pharmaceutical Compliance Pharmaceutical Risk Management Pharmaceutical Leadership Pharmaceutical Sales Pharmaceutical Training Global_Health_Initiatives Healthcare_Access Patient-Centered_Care Clinical_Research Health_Services_Research Pharmaceutical_Research Pharmaceutical_Logistics Women's_Health Drug_Formulary_Management Geriatric_Health Pharmaceutical_Business_Development Pharmaceutical_Marketing_Strategies Pharmaceutical_Networking Pharmaceutical_Quality_Assurance Pharmaceutical_Supply_Management |
| gptkbp:hasImpactOn |
Global_Health
|
| gptkbp:hasInfluenceOn |
Healthcare
Pharmaceutical Industry |
| gptkbp:hasLegalStatus |
Innovations in medicine
|
| gptkbp:hasLocation |
gptkb:New_York
|
| gptkbp:hasOccupation |
Pharmaceutical Executive
|
| gptkbp:hasPartnershipsWith |
Various healthcare organizations
|
| gptkbp:hasRole |
Chairman
|
| https://www.w3.org/2000/01/rdf-schema#label |
Charles Pfizer III
|